Montefiore in the News

Transformational Impact for Cancer Research, Clinical Care, and Models for Health Equity in the Bronx and Nationwide

September 12, 2023—(BRONX, NY)—The newly renamed Montefiore Einstein Comprehensive Cancer Center (MECCC) has been awarded comprehensive designation by the National Cancer Institute (NCI) of the National Institutes of Health, the ultimate standard achieved by only 55 other NCI cancer centers in the U.S. Through NCI’s peer-review process, MECCC was nationally recognized for its paradigm-shifting, practice-changing, policy-impacting cancer-focused science. As a result, MECCC was awarded a five-year, $20 million Cancer Center Support Grant to advance the translation of novel cancer research into new treatments, new screening and diagnostic tools, and equitable access to care throughout the Bronx, Westchester county, and the lower Hudson Valley.

“We are deeply honored to be recognized for the unique and special contributions of our cancer center in the NCI’s portfolio of comprehensive cancer centers,” said Edward Chu, M.D., M.M.S., director of MECCC, Carol and Roger Einiger Professor of Cancer Medicine and professor of oncology, medicine, and molecular pharmacology at Albert Einstein College of Medicine, and vice-president of cancer medicine at Montefiore Medicine. “This NCI designation is a testament to the remarkable strength of our exceptional science integrated with extraordinary multidisciplinary patient care.”

“We are proud of the entire team at the cancer center,” said Philip O. Ozuah, M.D., Ph.D., president and CEO of Montefiore Medicine, the umbrella organization for Albert Einstein College of Medicine and Montefiore Health System. “Our ongoing strategic investments and transformative institutional support ensures that Montefiore Einstein will continue to redefine medical excellence and be at the forefront of new discoveries and treatments that serve our patients with cancer and our community as a whole.”

A National Model for Addressing Health Equity

From genetic variants to systemic inequities and social determinants of health, MECCC investigators strive to uncover the drivers of cancer disparities and develop interventions that result in better outcomes.

“The progress made by the cancer center over the past several years has earned it comprehensive status,” said Henry Ciolino, Ph.D., director of the Office of Cancer Centers at the NCI. “And they did this serving one of the most diverse and medically challenged catchment areas of any NCI-designated cancer center.”

MECCC has built strong partnerships with community-based organizations throughout the Bronx, forging ties that bolster promotion of cancer screenings and other preventive measures specific to our borough’s needs and concerns. MECCC reviews and analyzes social determinants of health to enhance patient care and provide comprehensive support services, as well as inform health outcomes and health services research.

“We are a national model for community outreach, engagement, and cancer health equity,” said Dr. Chu. “As the diversity of our country’s population continues to grow, our understanding of cancer health disparities deepens and our principles of diversity, equity, and inclusivity are actively implemented. It is absolutely critical that we do everything within our power to ensure that all patients receive the highest quality care they need and deserve.”

MECCC is dedicated to educating and training the next generation of cancer investigators and physician-scientists through pathway programs that begin as early as high school. Initiatives such as BEYOND ALBERT, a summer and afterschool program for Bronx high school students who learn in the labs of MECCC members and the Einstein Discover Research Program, an 18-month biomedical research training program for M.S. candidates at the City University of New York’s Lehman College, offer unique opportunities for individuals from historically underrepresented groups in medicine and science.

A History of Exceptional Science and Patient Care

MECCC is the fourth oldest NCI-designated cancer center, having been originally designated by the NCI in 1972. For over 50 years, MECCC has been at the forefront of innovative cancer treatments. It was among the first to integrate academic research and clinical care, leveraging Albert Einstein College of Medicine expertise in cancer science and therapeutics as well as Montefiore Health System’s experience in providing comprehensive, compassionate care for more than 200 types of cancer.

MECCC is home to five members of the National Academy of Sciences and conducts novel research in the areas of Tumor Microenvironment and Metastasis, Stem Cell and Cancer Biology, Cancer Therapeutics, and Cancer Epidemiology, Prevention and Control. More than 1,000 patients each year enroll in the cancer center’s 300 active clinical trials, many of which provide access to cutting-edge treatments unavailable elsewhere.

                                                                                               ###

About Montefiore Einstein Comprehensive Cancer Center 

Montefiore Einstein Comprehensive Cancer Center (MECCC) is a National Cancer Institute (NCI)-designated comprehensive cancer center and a national leader in cancer research and care located in the racially and ethnically diverse borough of the Bronx, N.Y. MECCC combines the exceptional science of Albert Einstein College of Medicine with the multidisciplinary and team-based approach to cancer clinical care at Montefiore Health System. Founded in 1971 and an NCI-designated cancer center since 1972, MECCC is redefining excellence in cancer research, clinical care, education and training, and community outreach and engagement. Its mission is to reduce the burden of cancer for all, especially people from historically underrepresented groups.